Opicapone Completed Phase 3 Trials for Parkinson's Disease (PD) Treatment

Indications	Status	Purpose	Phase
DBCOND0053495 (Parkinson's Disease (PD))	Completed	Treatment	3

clinicaltrials.gov Identifier	Title	Drugs
NCT01851850	Continuation Treatment Protocol for Patient Who Participated in the BIA 9-1067-302 Clinical Trial	Opicapone (DB11632)
NCT01568073	Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon	Benserazide (DB12783) Carbidopa (DB00190) Entacapone (DB00494) Levodopa (DB01235) Opicapone (DB11632)
NCT01227655	Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.	Benserazide (DB12783) Carbidopa (DB00190) Levodopa (DB01235) Opicapone (DB11632)